Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/509414

The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation

Zhang, M.·Wang, B.·Urabe, G.·Huang, Y.·Plutzky, J.·Kent, K. C.·Guo, L.-W.
View original source ↗Export metadata ↓

Abstract

BackgroundVein-graft bypass is commonly performed to overcome atherosclerosis but is limited by high failure rates, principally due to neointimal wall thickening. Recent studies reveal that endothelial-mesenchymal transition (EndoMT) is critical for vein-graft neointima formation. BETs are a family of Bromo/ExtraTerminal domains-containing epigenetic reader proteins (BRD2, BRD3, BRD4). They bind acetylated histones through their unique tandem bromodomains (BD1, BD2), facilitating transcriptional complex formation and cell-state transitions. The role for BETs, including individual BRDs and their unique BDs, is not well understood in EndoMT and neointimal formation.\n\nMethods and ResultsRepression of BRD4 expression abrogated TGF{beta}1-induced EndoMT, with greater effects than BRD2 or BRD3 knockdown. An inhibitor selective for BD2 in all BETs, but not that for BD1, blocked EndoMT. Moreover, expression of a dominant-negative BRD4-specific BD2 fully abolished EndoMT. Concordantly, BRD4 knockdown repressed TGF{beta}1-stimulated increase of ZEB1 protein - a transcription factor integral in EndoMT. In vivo, lentiviral gene transfer of either BRD4 shRNA or dominant negative BRD4-specific BD2 mitigated neointimal development in rat jugular veins grafted to carotid arteries.\n\nConclusionsOur data reveal the BD2 domain of BRD4 as a determinant driving EndoMT in vitro and neointimal formation in vivo. These findings provide new insight into BET biology, while offering prospects of specific BET domain targeting as an approach to limiting neointima and extending vein graft patency.

Source connections

Explore related subjects

pathologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, M., Wang, B., Urabe, G., Huang, Y., Plutzky, J., Kent, K. C., Guo, L.-W.. 2019-01-04. The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation. https://doi.org/10.1101/509414

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Failed allogeneic corneal lenticules show fibrosis and identity loss without dominant T cell rejection

Failed allogeneic corneal stromal lenticules develop progressive opacity, but the state of the implanted tissue is unknown. Here we show that six explants from three patients occupy a fibrotic integration-failure state with scar-matrix production and loss of corneal identity without a dominant T cell rejection program. Scar-matrix, transparency and corneal-identity programs separated every patient from eight unimplanted donor controls, the last defined by independent human single-cell references. Calibrated immune programs and repertoire reconstruction distinguished the explants from canonical adaptive rejection. Exchange reduced interface reflectivity initially, followed by recurrent opacity in two patients and corneal steepening with declining uncorrected acuity in the third. In non-scarring rabbit repair, identity moved toward the uninjured state as backscatter returned toward normal despite increasing similarity to the explant-derived expression signature. Within one culture experiment, marked scar suppression accompanied opposite identity responses. Tacrolimus and rapamycin likewise suppressed canonical rejection while moving identity in opposite directions. Resveratrol combined reduced scar-associated programs and increased identity with improved graft appearance in the source study. These findings establish classic-rejection activity and tissue integration as separable axes and direct treatment of failed lenticules from escalating immunosuppression toward control of stromal remodeling and preservation of corneal identity.

pathology↗
bioRxiv2026

Transmural Single-Nucleus Transcriptomics Nominates Candidate Disease Programs in Human Necrotizing Enterocolitis

Background & Aims: Necrotizing enterocolitis (NEC) is a life-threatening disease of premature infants marked by inflammation, ischemia, mucosal injury, and, in advanced cases, necrosis extending into deeper layers of the intestinal wall. Because NEC affects specialized, interacting cells in a developing intestine, we used single-nucleus transcriptomics to build a transmural, cell-type-resolved map and nominate hypothesis-generating disease programs distinct from maturation. Methods: Full-thickness intestinal specimens from fetal/prenatal controls, acute NEC cases, and infant controls were analyzed by single-nucleus RNA sequencing (snRNA-seq). Fetal and infant samples served as developmental references. Analyses included cell annotation, NEC-versus-infant differential expression, gene ontology (GO), cross-lineage recurrence, cell death signatures, and developmental maturity. Results: We profiled 53,735 nuclei by snRNA-seq and resolved 34 epithelial, stromal, vascular, immune, neuronal, glial, and smooth muscle populations. We used a morphology-based nuclei scoring system for sample selection that predicted high-quality transcript recovery. NEC nuclei were represented across this cellular landscape, with recurrent gene-expression changes suggesting shared inflammatory recruitment, antimicrobial/redox defense, stress adaptation, complement/vascular activation, reduced homeostatic signaling, and cell death-associated regulation. Developmental maturity analysis identified fetal-like expression levels in subsets of NEC-regulated genes. Proliferative crypt populations retained DNA repair/cell-cycle programs with inflammatory, hypoxic, and ER-stress features, while absorptive enterocytes showed reduced digestive, transport, detoxification, and terminal villus-function programs. Secretory-lineage changes implicated goblet mucus-barrier responses with reduced glycosylation, trafficking, and hydration; enteroendocrine changes in epithelial defense, metabolic stress, and neural signaling; and Paneth cell retention of antimicrobial effector transcripts despite altered ER quality control, autophagy, and granule delivery in NEC. Non-epithelial programs implicated stromal Wnt/BMP niche loss, impaired lymphatic drainage/scavenging, macrophage cytokine activation with reduced clearance machinery, neuroglial circuit defects, and altered smooth muscle contraction-relaxation balance. Conclusions: This single nuclear intestinal cell atlas nominates multicellular programs that may govern NEC initiation, progression toward tissue destruction, and resolution toward functional recovery.

pathology↗
bioRxiv2026

Explainable Multimodal Prognostic Modeling Uncovers New Clinically Relevant Pathological Features in a Multi-Institutional Pancreatic Neuroendocrine Tumor Cohort

Although many patients with a well-differentiated pancreatic neuroendocrine tumor (PanNET) are cured after surgical resection, it is hard to predict outcome in these patients. Current prognostic assessment relies largely on Ki-67 proliferation index, tumor stage, and established adverse pathologic features, such as vascular and perineural invasion. However, individually, these variables incompletely explain why patients with similar clinicopathologic profiles sometimes experience markedly different outcomes. To address this challenge, we assembled three independent cohorts with a surgically resected PanNET. In total, we included 1,438 patients with approximately 30,000 histology images, and approximately 12,000 person-years of follow-up. We separately modeled structured clinicopathologic information with Cox regression and tumor-centered pathology images with deep learning on an internal cohort treated at Johns Hopkins Hospital and performed multimodal continuous-time survival modeling to reveal which clinical and pathologic features are most important in predicting patient outcome. Across Cox models of censored time to recurrence-free survival, a text-based clinicopathological model that incorporated known prognosticators achieved a C-index of approximately 0.87, the image-based histology model approximately 0.80, and decision-level late multimodal fusion approximately 0.88 on the internal test set. The clinical model demonstrated strong prognostic discrimination using established risk factors, mainly relying on the TNM stage and Ki-67 index. Primary tumor histology retained substantial prognostic signal, with analysis restricted to tumor-centered regions to reduce reliance on unrelated tissues that might indirectly indicate disease extent. Interpretation of high-attention image tiles revealed regions of importance in the primary tumor, including recognized adverse morphologic features such as the leading edge of the tumor and foci of vascular or perineural invasion. Unexpectedly, intratumoral and peritumoral stroma accounted for nearly 50% of the model's high-attention regions, suggesting that the stroma may yield equal prognostic information to neoplastic cells in recurrence-prediction models. To test generalizability, we further evaluated the trained models in independent cohorts from two institutions with different demographics, where discrimination varied by site (mean late-fusion C-indices of 0.864 and 0.723). Together with the improved discrimination achieved through late fusion, our findings suggest that current clinicopathologic variables can be modeled to form reliable prognosticators, and that routine hematoxylin and eosin (H&E) stained slides of the primary tumor contain additional prognostically important information not fully captured by conventional clinicopathologic assessment, such that together, the two sources provide complementary information.

pathology↗